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SUMMARY
 
class II and class III patients and compare them to those of a control group. 
 Twenty skeletal Class II and 20 skeletal Class III patients who under-
had impacted third molars extracted were in the control group.  During the orthognathic surgery, 
tissue samples were taken from the tuber maxillae, ramus mandibulae anterior and posterior part 
together with mucosa from the gingival transitory fold in the second molar region of the lower 
expression. The distributions of these factors were assessed semiquantitatively. 
of the study group. FGFR1 expression was more pronounced only in mucosa. VEGF and MMP2 
were found only in some tissue samples. More apoptotic cells were observed in the bone tissue 
and soft tissue of the control patients than in those of the skeletal Class II and Class III patients, 
in which apoptotic cell frequencies were relatively equal. 
From bone tissue in tuber maxillae -
sion is seen in Class III and control groups, comparing to Class II. In ramus mandibulae anterior 
control group and Class II patients, while in ramus mandibulae posterior part higher expression of 
growth potential in these jaw bone regions. More active bone extracellular matrix protein (osteo-
calcin and osteopontin) expression in tuber maxillae region both in class II and class III patient 
groups and different expression in ramus mandibulae anterior part, prove to the bone mineralization 
and metabolism activity changes, which, perhaps, characterize just these dentofacial deformations.
 orthognathic surgery, bone, signalling molecules, immunohistochemistry.
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Most commonly, the skeletal morphology of 
dentofacial deformations involves jaw hypoplasia or 
hyperplasia (1, 2), which corresponds to Class II and 
Class III dentoalveolar malocclusion. Clinically, their 
jaw bone deformation manifestations are similar; how-
ever, X-ray cephalometry reveals these anomalies to 
have distinct skeletal morphologies (3), consistent with 
the multi-faceted aetiopathogenesis of these anomalies. 
Both the form and size of bones are constantly 
developing during the bone tissue remodelling pro-
cess, whereas at the cellular level, osteoclastic and 
osteoblastic cell lines function in coordination (4-6). 
Changes in the activities of these cell lines lead to 
deviations from the accepted norms of bone form and 
size (7). At the molecular level, the activity of these 
cells is induced and maintained by growth factors 
(8). Growth factors are main signaling molecules 
for growth and development in ante– and postnatal 
period. They are involved in cellular proliferation, 
differentiation and morphogenesis of tissues and 
organs during embryogenesis, postnatal growth and 
adulthood. The effect of growth factors is mediated 
through surface receptors on the target cells by acti-
vating intracellular phosphorylating enzymes, which 
in turn induce an intracellular signaling pathway by 
aggregation of co-factors and other proteins which 
migrate to the nucleus. Together with other tran-
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scription factors they activate a set of genes, which 
phenotype (9). 
The main growth factors important in bone 
-
blast growth factor (FGF), and vascular endothelial 
belongs to a large superfamily of related proteins that 
also includes bone morphogenetic proteins, growth 
and differentiation factors, activins and inhibins. Dur-
ing the early stages of bone formation, the action of 
to proliferate, providing a pool of early osteoblasts 
(10). Quite the opposite, during later phases of osteo-
mineralization (11). Bone morphogenetic proteins 
have the unique functions of inducing the differen-
tiation of cells of the osteoblastic lineage, therefore 
increasing the pool of mature cells and of enhancing 
the differentiated function of the osteoblast. Fibro-
blast growth factors during embryonic development 
play a critical role in morphogenesis by regulating 
cell proliferation, differention and cell migration but 
in adult organism FGF have an important role in the 
control of the nervous system, in tissue repair, wound 
healing and in tumor angiogenesis (12, 13). Vascular 
endothelial growth factor takes part in osteogenesis 
by recruitment of new blood supply, which provides 
the necessary osteoprogenitor cells (14, 15). 
An important aspect of the structure of bone tis-
sue lies in the composition, formation and degradation 
of intercellular material known as the extracellular 
matrix (16). MMP (matrix metalloproteinases) are 
secreted from connective tissue cells, can break down 
many structural macromolecules in the connective 
tissue matrix. MMP activity is associated with physi-
ologic and pathologic conditions that involve matrix 
degradation and remodeling. 
Cell death is equally important because under 
physiological conditions, cells end their life-cycle 
by means of apoptosis (17, 18). 
The aim of this study was to assess the distri-
bution of signalling molecules important for bone 
remodelling in jaw bone growth zones of skeletal 
Class II and Class III patients in comparison with a 
control group. 
MATERIAL AND METHODS
Twenty skeletal Class II and 20 skeletal Class 
III patients who needed combined orthodontic and 
orthognathic surgery were included in the study. The 
mean age of the patients was 20.64±3.27 years. In 
the Class II group, there were 13 women and 7 men, 
whereas in the Class III group, there were 14 women 
and 6 men. Patients with a severe general disease at 
the time of the operation or the anamnesis, with a 
lip and/or palatal cleft, with a dentofacial syndrome 
or with skeletal asymmetry were excluded from the 
study. Biopsy samples were taken during orthognathic 
surgery from the jaw osteotomy sites in the upper 
(tuber maxillae) and lower jaw (ramus mandibulae 
anterior and posterior part) and from the lower jaw 
gingival transitory fold in the second molar region. 
The control group included 5 patients who under-
went extractions of impacted third molars with skel-
etal and dentoalveolar Class I and with no tooth row 
anomalies. The control group patients had not had any 
orthodontic treatment and lacked general illnesses, lip 
clefts, palatal clefts, dentofacial syndromes, and any 
-
tion. The mean age of the patients was 19.4±2.7 years; 
3 were women, and 2 were men. Tissue samples were 
taken from tuber maxillae and the anterior part of the 
ramus mandibulae, but considering the extraction 
method and in order not to cause extra tissue damage 
to the patient, tissue samples were not obtained from 
the posterior part of the ramus mandibulae. 
The tissue samples for the study were used in 
conformity with the permission of the Ethics Com-
mittee of Riga Stradins University. 
day in mixture of 2% formaldehide and 0,2% picric 
acid in 0.1 M phosfate buffer (pH 7.2). After samples 
were rinsed in thyroide buffer, containing 10% sacha-
-
bridge Science, UK), bone morphogenetic factor 2/4 
growth factor receptor 1 (FGFR1;  ab10646; Abcam, 
UK), vascular endothelial growth factor (VEGF, 
M7273; Dako, Denmark), matrix metalloproteinase 
2 (MMP2, AF902;  RD Systems, UK), osteocalcin 
(OC, ab13418; Abcam, UK) and osteopontin (OP, 
ab8448; Abcam UK).
Immunoreaction was visualized by the avidin-
biotin (LSAB) immunoperoxidase method using an 
LSAB kit (DakoCytomation, DK), and DAB (diam-
inobenzidine) solution (Dako, DK) was used as chro-
mogen, and hematoxylin was used as the counterstain. 
TUNEL reaction was used for detection of 
apoptosis (19). , POD 
(Roche Diagnostics) and DAB substrate (Vector) 
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and transferred to PBS (pH 7.5) for 10 min. Subse-
quently slides placed into 50 ml PBS solution with 
to block the endogenous peroxidases. Afterwards 
placed into 0.2 M boric acid (pH 7.0), placed into 
cooled to room temperature and rinsed with PBS. 
After that, slides were kept in refrigerator in 0.1% 
BSA (bovine serum albumin) solution with PBS for 
10 min and then incubated in TUNEL mix (Tdt – mix 
of terminal deoxynucleotide transferase and DIG-
labeled deoxynucleotide) for 1h at +37oC. Then the 
slides were rinsed with PBS 1:10, and incubated for 
30 min at +37ºC with POD (sheep anti-digoxygenin 
antibogy coupled with horseradish peroxidase Fab 
fragment). Then the slides were washed with PBS, 
covered with DAB (diaminobenzidine chromogen) 
for 7 min, and then rinsed with running water for 5 
min. For visualisation, a routine histological method 
was used and the samples were routinely stained with 
haematoxylin and eosin and microscopically analysed 
with a Leica BME microscope. 
To record the relative frequency of indices de-
tected by immunohistochemistry, a semi-quantitative 
counting method widely used in the literature was 
employed (20, 21). The appearance frequency of fac-
To process the data statistically, the number of cells 
-
-
The data were analysed using descriptive and 
analytical statistical methods. The mean values and 
standard deviations (SDs) were calculated. For hy-
pothesis testing, appropriate parametric (t test and 
dispersion analysis (ANOVA)) and non-parametric 
(Kruskal-Wallis and Mann-Whitney) methods were 
used. To compare two or more variables, correlation 
of range scale values were calculated with the Spear-
measured values were calculated with the Pearson 
RESULTS
mucosa
Routine review picture of the soft tissue revealed 
gingival epitheliocyte vacuolisation and basal cell hy-
perplasia in the epithelium of both Class II and Class 
III patients, together with irregularly thickened basal 
subepithelial connective tissues (Fig. 1a). 
Bone material from the anterior ramus mandibu-
lae and posterior trabecules contained chaotically 
osteon structures. In the osteon canals, irregular 
connective tissue ingrowths and blood vessel scle-
rotisation were observed (Fig. 1b). Tuber maxillae 
bone tissue also had irregular bone mineralisation, 
and osteon canal obliteration and connective tissue 
proliferation were observed (Fig. 1c).
The bone and mucosal tissue of the control 
group were without marked structural changes and 
presented a histological picture corresponding to the 
common standard.  
Analysis of the expression of the studied growth 
factors, bone extracellular matrix proteins and degen-
eration enzymes in the jaw bones and surrounding soft 
tissues in skeletal Class II, Class III and control group 
patients (Table 1) revealed that the expression of these 
biological markers is rather variable; however, in all 
Fig. 1. Microphotograph of oral mucosa from the region of the lower second molar in a class III patient showing gingival epi-
theliocyte vacuolisation and basal cell hyperplasia (a), bone from the ramus mandibulae anterior part of a Class II patient with, 
irregular connective tissue ingrowths and blood vessel sclerotisation in the osteon canals (b), bone with irregular mineralisation 
from the tuber maxillae of a Class III patient (c)
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the study groups, the expression of 
those markers mainly responsible 
for bone remodelling was pro-
BMP2/4 (Fig. 2b), OC (Fig. 3a) and 
OP (Fig. 3b) in the bone tissue of the 
tuber maxillae and the anterior and 
posterior ramus mandibulae of the 
study group. 
The expression the growth 
factor receptor FGFR1 was found 
to be more pronounced only in the 
soft tissues from the lower jaw gin-
gival transitory fold in the second 
molar region in comparison to its 
expression in bone tissue. Vascu-
lar endothelial growth factor and 
the degeneration enzyme MMP2 
were found only in two Class II 
patients gingival tissues, whereas 
in the control group, no posi-
tive signals for VEGF or MMP2 
were observed in any of the tissue 
samples. In the control group, the 
expression of biological markers in 
the tuber maxillae and anterior ramus mandibulae is 
rather similar. However, in Class III patients, higher 
expression is observed only in the bone tissue from 
the tuber maxillae and ramus mandibulae posterior 
parts, whereas in the Class II tissue samples, higher 
expression was observed in the tuber maxillae and 
ramus mandibulae anterior part.
Analyzing the mean number of apoptopic cells 
in the bone tissue from tuber maxillae class II, class 
III and in the control patient groups, we found that a 
Fig. 2. 
Fig. 3. Microphotograph of osteocalcin expression in the tuber maxillae of a Class 
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+++
- +++ +++
BMP2/4 0/+ + + 0 + + + +/++ + +/++ + ++ - 0 0/+
FGFR1 +* + + ++* +++ ++* + +/++ +++* +++ + - - - -
VEGF 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0
OC +++ ++ + - - +++ + - - - ++/ 
+++
+++ - - -
OP +/++* +/++ +/++ - - ++* 0/+ - - - +++* +++ - - -
MMP2 0 0/+* 0 0 0 0/+ 0* 0 0 0/+ 0 0* - 0 0
-
-
Table 1. Mean protein expression indices of growth factors, bone extracellular matrix proteins and degeneration enzymes in 
the jaw bones and soft tissues in the patient groups
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-
optotoc cells in tuber maxillae bone tissue, there in 
receptor 1 (FGFR1) amount in the tissues, which 
gives the evidence to a moderately close statistically 
Analyzing the correlations in the tissue material 
from ramus mandibulae anterior part (see Table 3), 
there increases the number of apoptotic cells, since 
both of these indices correlated between each 
from ramus mandibulae anterior part there exists a 
between the number of apoptotic cells and BMP2/4 
-
sue from ramus mandibulae posterior part (see Table 
-
close positive correlations were observed for any of 
the studied morphological parameters in the mucosal 
epithelium acquired from the second molar region.
DISCUSSION
The mucosal changes found in skeletal Class II 
and Class III patients, who are characterised by epi-
theliocyte focus-type vacuolisation, cell hyperplasia, 
-
et 
 (23) found similar gingival morphological changes 
treatment. In the bone tissue of the patients under 
study, irregular mineralization with vascular sclerosis 
and connective tissue proliferation in osteon canals 
was observed, which could be associated with insuf-
-
per and lower jaw growth in patients with dentofacial 
deformations. 
Our results indicate that patients with skeletal 
dentofacial deformations have a greater amount of 
relative positive structures for important growth factors 
that are well recognised in bone tissue morphogenesis 
matrix proteins (OP and OC), with slight differences 
between the study groups, indicating the importance 
of these morphological markers in supportive tissue 
remodelling and the development of bone tissue in 
greater number of apoptotic cells were in the control 
group (mean value 25.89±11.34 cells in the visual 
of apoptopic cells is practically equal and less than 
in the control group (mean values respectively are 
9.42±19.56 and 9.25±9.53). Also in the tissue mate-
rial from ramus mandibulae anterior part the apop-
topic cell number in the control group is the greatest 
(mean value 28.44±6.45), but in class II and class III 
patients the apoptopic cells are seen to be in a lesser 
amount (mean values respectively are 10.84±10.52 
and 11.86±13.38). Number of apoptotic cells in ra-
mus mandibulae posterior part in class II and class 
III patient groups mean values respectively were 
7.27±11.74 and 5.73±5.19 cells. 
Analyzing the cross-correlations in tuber maxil-
lae (see Table 2) we found out that there existed a 
and the bone morphogenetic protein 2/4 (BMP2/4) 
Fig. 4. Microphotograph of apoptotic cells in ramus 
mandibulae anterior part of a Class III patient (TUNEL, 
BMP2/4 FGFR1 OC MMP2 
BMP2/4 r 0.415 1    
p     
FGFR1 r -0.070 0.077 1   
p 0.764 0.748    
OC r 0.512 0.288 -0.449 1  
p 0.279 0.166   
MMP2 r 0.087 0.308 -0.309 0.270 1
p 0.701 0.175 0.213 0.397  
TUNEL r 0.287 0.249 0.272 -0.296
p 0.249 0.352 0.393 0.325
-
OC – osteocalcin, MMP2 – matrix metalloproteinase 2, TUNEL – 
Table 2. Cross-correlations between the growth factors, bone 
extracellular matrix proteins, degeneration enzymes and apoptotic 
cells expression in the tuber maxillae
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patients with dentofacial deformations. In all tissue 
BMP 2/4 showed high levels in tissue samples from 
the anterior and posterior ramus mandibulae and in 
the tuber maxillae, which partially supports the data 
of Suttapreyasri  (24). 
In the present study, OP was the most dominant 
noncollagenous extracellular bone matrix protein 
in the control group. OP is an early marker of bone 
matrix, whereas OC is a late marker (25).  Sasano et 
 (26) suggested that bone matrix proteins continue 
to accumulate in the matrix as embryonic osteogen-
esis proceeds, and bone expands its area with more 
intense OP deposition at the periphery, which consists 
of immature matrix components, and lower OP levels 
in the central parts of bone that are more mature. 
as OP expression was relatively uniform throughout 
the bone, with increased staining near periosteum.  
OC is produced by mature osteoblasts, odonto-
blasts and chondrocytes. In a study with OC knock-
out mice, Ducy  (27) reported no abnormal 
phenotype until 6 months of age because there was 
markedly higher bone mass and bones of improved 
demonstrate very inconsistent OC expression, sug-
gesting that there could be some disturbances in 
osteocalcin-depending bone remodelling.
Similar and marked expression of FGFR1 in the 
oral mucosa of all groups' tissue samples indicates 
the importance of this growth factor receptor in soft 
tissues. Therefore, we can conclude that oral mucosa 
-
cial because skeletal Class II and Class III patients 
undergo orthognathic surgery with intraoral inci-
sions, and this factor’s dominant expression should 
promote rapid convalescence of the oral mucosa after 
the operation.  The expression of FGFR1 in the tuber 
maxillae and ramus mandibulae posterior part was 
less pronounced in Class II patients than in Class III 
-
ling processes. This possibility is consistent with the 
results of Jacob  (28), who demonstrated that 
signalling through FGFR1 in osteoblasts is neces-
sary to maintain the balance between bone formation 
and remodelling through a direct effect on osteoblast 
maturation. They suggest that the predominant role 
for FGFR1 signalling in mature bone is to decrease 
anabolic activity and slow the terminal differentiation 
(mineralisation) of osteoblasts.
Weak MMP2 expression and a virtual lack of 
VEGF expression in the patients’ tissues indicates that 
and Class III patients' bone remodelling. 
Jilka  (29) suggested that the prevalence of 
osteoblast apoptosis is much lower in human bone 
than in mouse bone. This difference results from two 
reasons: human osteoblasts live longer and are fewer 
in number compared to their murine counterparts 
because bone turnover in humans is lower. This differ-
ence could also be associated with the total number of 
osteoblasts; the more osteoblasts observed in a biopsy 
section, the more apoptotic cells were also observed. 
In our study, the greatest numbers of apoptotic cells 
were observed in the bone and soft tissues of the 
control patients, whereas the lower and relatively 
BMP2/4 FGFR1 OC MMP2
BMP2/4 r     0.427 1    
p     
FGFR1 r -0.037 -0.073 1   
p 0.836 0.691    
OC r 0.522 0.246 -0.057 1  
p 0.309 0.835   
MMP2 r 0.083 -0.064 1
p 0.708 0.794 .000  
TUNEL r 0.502 0.130 -0.251
p 0.595 0.387
-
OC – osteocalcin, MMP2 – matrix metalloproteinase 2, TUNEL – 
Table 3. Cross-correlations between the growth factors, bone 
extracellular matrix proteins, degeneration enzymes and apoptotic 
cells expression in ramus mandibulae anterior part
 BMP2/4 FGFR1 OC
BMP2/4 r 0.121 1   
p 0.694   
FGFR1 r 0.595 0.052 1  
p 0.867  
OC r 0.943 0.500 0.866 1
p 0.057 0.667 0.333
TUNEL r 0.045 0.515 -0.136 0.730
p 0.890 0.105 0.674 0.161
TUNEL r 0.548 0.502 0.036 0.130
p **0.003 **0.009 0.865 0.595
factor receptor 1, OC – osteocalcin, TUNEL – apoptotic 
-
Table 4. Cross-correlations between the protein expression 
of growth factors, bone extracellular matrix proteins and 
degeneration enzymes in ramus mandibulae posterior part 
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equal numbers of apoptotic cells in skeletal Class II 
and Class III patients could indicate an imbalance be-
tween cell proliferation, differentiation and apoptosis. 
CONCLUSIONS
From bone tissue in tuber maxillae region the 
Class III and control groups, comparing to Class II, 
which, probably, suggests to a potentially probable, yet 
not expressed bone growth in these region. In ramus 
mandibulae 
higher in the control group and Class II patients, while 
in ramus mandibulae posterior part higher expression 
-
ing to Class II, which indicates to a preserved growth 
potential in these jaw bone regions. FGFR1 similar 
expression and practically lack of VEGF expression 
factors in skeletal Class II and Class III patients bone 
remodelling. The same can be referred also to MMP2 
unpronounced expression in the Class II, Class III and 
control groups. More active bone extracellular matrix 
protein (osteocalcin and osteopontin) expression in 
tuber maxillae region both in Class II and Class III 
patient groups and different expression in ramus man-
dibulae anterior part, prove to the bone mineralization 
and metabolism activity changes, which, perhaps, 
characterize just these dentofacial deformations. 
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